Overview FMS European Long-Term Study Status: Completed Trial end date: 2008-10-01 Target enrollment: Participant gender: Summary Investigation of the long-term (12 months) efficacy and safety of milnacipran used in the treatment of fibromyalgia syndrome. Phase: Phase 3 Details Lead Sponsor: Pierre Fabre MedicamentTreatments: LevomilnacipranMilnacipran